^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
utomilumab (PF-05082566)
i
Other names: PF05082566, PF2566, PF5082566, PF 05082566, PF 2566, PF 5082566, PF-05082566 , PF-2566, PF-5082566
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Novartis, Pfizer
Drug class:
CD137 agonist
Related drugs:
